Actemra and Joint swelling - a phase IV clinical study of FDA data

Summary:

We study 85,119 people who have side effects when taking Actemra. Joint swelling is found, especially among people who are female, 40-49 old, have been taking the drug for 2 - 5 years, also take Enbrel and have Pain.

The phase IV clinical study analyzes which people take Actemra and have Joint swelling. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 20, 2023

85,119 people reported to have side effects when taking Actemra.
Among them, 15,891 people (18.67%) have Joint swelling.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 97,637 Actemra users.

What is Joint swelling?

Joint swelling is found to be associated with 3,473 drugs and 2,861 conditions by eHealthMe. Currently, we are studying 134,313 people who have Joint swelling.

Number of Actemra and Joint swelling reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Actemra and have Joint swelling?

Check whether Joint swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Joint swelling and when was it recovered:

Joint swelling in Actemra

Expand to all the drugs that have ingredients of tocilizumab:

Joint swelling and drugs with ingredients of tocilizumab (7,711 reports)

Alternative drugs to, pros and cons of Actemra:

Actemra (97,637 reports)

Browse all side effects of Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Joint swelling treatments and more:

Joint swelling (134,313 reports)

Common drugs associated with Joint swelling:

All the drugs that are associated with Joint swelling:

Joint swelling (3,473 drugs)

Common conditions associated with Joint swelling:

Rheumatoid arthritis: 43,452 reports
High blood pressure: 5,948 reports
Pain: 5,108 reports
Psoriasis: 4,042 reports
Osteoporosis: 2,823 reports

All the conditions that are associated with Joint swelling:

Joint swelling (2,861 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tocilizumab (the active ingredients of Actemra) and Actemra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.